Improving pharmaceutical manufacturing – one technology at a time


Our Foundation

Our foundation is strongly connected to Bausch+Ströbel SE + Co. KG, a globally trusted partner for supply in Fill & Finish, with which we share a close strategic partnership.

We are a young, agile, highly motivated, lateral thinking and interdisciplinary team of biotechnologists, IT experts, engineers and process engineers.

 
„Every once in a while, a new technology, an old problem, and a big idea turn into an innovation.“
“Dean Kamen” (US inventor and entrepreneur)

Our Focus Fields

Vaccines and Cell and Gene Therapy have become the staple innovation fields of the pharmaceutical industry. We want to be at the forefront. Improving production methods and capabilities. Thereby helping pave the road for a healthier future.

Get to know our projects now!

INACTIVATE

High-speed pathogen inactivation Large versatility for labs & industry Designed for your needs

MOSAIC

Personalized cell & gene therapy Flexible & modular system Fully automated & scalable platform

Meet Our Team

Dr. Andrea Traube

Chief Executive Officer

Lena Schober

Director Business Development & Applications

Tobias Mugele

Director Technical Development INACTIVATE

Holger Saal

Director Technical Development MOSAIC

Advisory Board

Dr. Hagen Gehringer

Member of the Executive Board
Bausch+Ströbel

Simon Ackermann

Director Development Platform Standardisation
Bausch+Ströbel

Thomas Seiffer

Director Research, Technology and Pharma Services
Bausch+Ströbel

Peter Kitschmann

Principal Consultant Pharma, GxP and Processes Bausch+Ströbel

Dipl.-Phys. Martin Thoma

Gruppenleiter Geräte- und Technologieentwicklung
Fraunhofer IPA

Dr. Sebastian Ulbert

Deputy Director, Head Department of Vaccines and Infection Models
Fraunhofer IZI

TO REVOLUTIONIZE THE THINKING OF PHARMACEUTICAL MANUFACTURING

Get in contact & partner with us

Let’s schedule our talk now!

Dr. Andrea Traube

Chief Executive Officer, KyooBe Tech GmbH